Cancer Home > Panitumab

Were you looking for information about Panitumumab? Panitumab is a common misspelling of panitumumab.
Panitumumab (Vectibix®) is a medication that is available by prescription only. It is approved for treating a type of colorectal cancer that has a certain protein called epidermal growth factor receptor (EGFR) on the surface of the cancer cells. Panitumumab works by binding to this protein, which helps slow down the growth of the cancer cells. A healthcare provider will administer the drug using an intravenous (IV) infusion every 14 days.
(Click Panitumumab for more information about how it works, side effects to look out for during treatment, and when and how the medication is administered. You can also click any of the links in the box to the right for specific information.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.